RT @StephenVLiu: Phase II TROPiCS-03 study of sacituzumab govitecan (TROP2 ADC) in previously treated #SCLC @JTOonline. RR 42% (35% in plat…

Congratulations to our incoming fellows!

RT @n8pennell: 😊 Join us!

RT @n8pennell: I am pleased to share that I am running for the Board of Directors in the ASCO Election. Learn more about me and the 12 othe…

@AmandaNizamMD @PGrivasMDPhD @ClevelandClinic @koshkin85 @arnabguonc @HamidEmamekhoo @KMittalmd @PBarataMD Congratulations Amanda!! Well deserved

Thank you @IASLC for the opportunity to present our research on radiomic biomarkers to predict response to ICI rechallenge for recurrent NSCLC as an oral abstract at #WCLC24!! Very proud of our team's work in this space @anantm @n8pennell @jpssr2 @Maedezkn

@LemmonOnc @LoganRoofMD @BMuthusamyMD Was amazing to see you guys and catch up! Sorry to have missed you this weekend @LoganRoofMD

RT @DrJNaidoo: #WCLC24 Presidential I Ph III HARMONI-2 ivonescimab v pembro in PDL>1% NSCLC: - 398pts - PFS HR 0.51 (11.1 v 5.82 mPFS) - b…

RT @FordePatrick: With the goal of addressing a key clinical question, which pts w lung cancer may benefit from adjuvant immunotherapy afte…

RT @jrgralow: .@asco board member and chair of ASCO AI Task Force @dapattmd discusses newly released ASCO principles for responsible use of…

RT @StephenVLiu: Overview of outcomes with 1L osimertinib @JTOonline. At progression, continuation of osimertinib associated with shorter s…

@HundalJasmin @sitcancer Congratulations Jasmin!!

RT @BMuthusamyMD: 🚨🚨 Folks involved with thoracic oncology - please take this IASLC survey, I'm part of the educational committee, and this…

@ThejusJay @aakonc @SKamath_MD @sangwan_naseer @CleClinicMD @SpringerNature @Nature_NPJ Amazing work! Congratulations on the publication TJ.

RT @ThejusJay: Publication alert 📢 We use "#multiomics machine learning to study host-#microbiome interactions in early-onset vs average-on…

RT @jamecancerdoc: We are excited to welcome an outstanding group young doctors - as freshly minted Hematology and Medical Oncology Fellows…

RT @oncodaily: @jamecancerdoc @LukasDelasos @ClevelandClinic @CleClinicMD @n8pennell @ccfhemonc @CCF_IMCHIEFS We would like to inform you t…

RT @jamecancerdoc: Please join me in congratulating and welcoming @LukasDelasos new member of @ClevelandClinic Thoracic Oncology Program an…

@jamecancerdoc @ClevelandClinic @CleClinicMD @n8pennell @ccfhemonc @CCF_IMCHIEFS Thank you @jamecancerdoc !! Very excited to join the amazing team we have at Taussig!